Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors.

DOI:10.1007/s12072-025-10825-3
作者：Kaori Matsumoto,?Tatsuo Kanda,?Junichiro Wakatsuki,?Young-Jin Kim,?Ritsuko Yokouchi,?Naho Sato,?Yuko Hasegawa,?Kenji Amemiya,?Yosuke Hirotsu,?Sumio Hirose,?Yushi Imai,?Shinya Takaoka,?Hiroyuki Amano,?
文献类型：期刊论文
补充材料：只需要正文